Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Carlsmed, Inc.
CARL · SEC Filings
website
127
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI...
Price
16.05
Market Cap
438.21 M
Float
10.23 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about CARL
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Carlsmed, Inc.
CARL · SEC Filings
10.23 M
Float
16.05
Price
438.21 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 5, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 5, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 6, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 28, 2025
News
TYPE
HEADLINE
FILED AT
8-K
Carlsmed Appoints Richard Heppenstall as Chief Financial Officer and Reaffirms Fiscal Year 2026 Guidance
Sep 30, 2026
8-K
Carlsmed, Inc. Appoints Jeff Bertolini as Chief Operating Officer
Sep 8, 2026
8-K
Carlsmed Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance
Aug 5, 2026
8-K
Carlsmed, Inc. Announces Results of 2026 Annual Meeting of Stockholders
Jun 3, 2026
8-K
Carlsmed Reports First Quarter 2026 Financial Results and Raises Full Year Revenue Guidance
May 5, 2026
8-K
Carlsmed Reports Strong Q4 and Full Year 2025 Financial Results with Significant Revenue Growth
Feb 25, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B4
SHARE RESALE REGISTRATION | Shares amount: 6,700,000 | Share price: $15 | | Offering amount: $100,500,000
Jul 24, 2025
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Oct 1, 2026
S-3
August 2026 SHELF
Aug 14, 2026
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 25, 2026
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 24, 2025
8-A12B
Form 8-A12B - Registration of securities [Section 12(b)]
Jul 21, 2025
S-1/A
SHARE RESALE REGISTRATION | Shares amount: 6,700,000 | Share price: $15
Jul 15, 2025
Proxies
TYPE
HEADLINE
FILED AT
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 22, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 22, 2026
Ownerships
TYPE
HEADLINE
FILED AT
4
Bertolini Jeffrey (Reporting)
Nov 4, 2026
144
Form 144 - Report of proposed sale of securities
Nov 3, 2026
4
Bertolini Jeffrey (Reporting)
Nov 2, 2026
144
Form 144 - Report of proposed sale of securities
Oct 30, 2026
144
Form 144 - Report of proposed sale of securities
Oct 14, 2026
4
Bertolini Jeffrey (Reporting)
Oct 6, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Aug 24, 2026
EFFECT
Form EFFECT - Notice of Effectiveness
Jul 23, 2025
CORRESP
Form CORRESP - Correspondence
Jul 18, 2025
CORRESP
Form CORRESP - Correspondence
Jul 18, 2025
CORRESP
Form CORRESP - Correspondence
Jul 15, 2025
CORRESP
Form CORRESP - Correspondence
Jul 7, 2025
